Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 317

    1.

    Remission of nephrotic-range albuminuria in type 1 diabetic patients.

    Hovind P, Rossing P, Tarnow L, Toft H, Parving J, Parving HH.

    Diabetes Care. 2001 Nov;24(11):1972-7.PMID: 11679467 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Improved survival in patients obtaining remission of nephrotic range albuminuria in diabetic nephropathy.

    Hovind P, Tarnow L, Rossing P, Carstensen B, Parving HH.

    Kidney Int. 2004 Sep;66(3):1180-6.PMID: 15327415 [PubMed - indexed for MEDLINE]Related articles

    3.

    Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively.

    Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH.

    Kidney Int. 2001 Jul;60(1):277-83.PMID: 11422762 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Smoking and progression of diabetic nephropathy in type 1 diabetes.

    Hovind P, Rossing P, Tarnow L, Parving HH.

    Diabetes Care. 2003 Mar;26(3):911-6.PMID: 12610058 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Remission of nephrotic-range albuminuria reduces risk of end-stage renal disease and improves survival in type 2 diabetic patients.

    Rossing K, Christensen PK, Hovind P, Parving HH.

    Diabetologia. 2005 Nov;48(11):2241-7. Epub 2005 Sep 17.PMID: 16170513 [PubMed - indexed for MEDLINE]Related articles

    6.

    Course of glomerular filtration rate in albuminuric type 2 diabetic patients with or without diabetic glomerulopathy.

    Christensen PK, Gall MA, Parving HH.

    Diabetes Care. 2000 Apr;23 Suppl 2:B14-20.PMID: 10860186 [PubMed - indexed for MEDLINE]Related articles

    7.

    Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?

    Andersen S, Tarnow L, Cambien F, Rossing P, Juhl TR, Deinum J, Parving HH.

    Diabetes Care. 2003 May;26(5):1501-6.PMID: 12716812 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients.

    Parving HH, Hommel E, Jensen BR, Hansen HP.

    Kidney Int. 2001 Jul;60(1):228-34.PMID: 11422755 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Natural course of kidney function in Type 2 diabetic patients with diabetic nephropathy.

    Christensen PK, Rossing P, Nielsen FS, Parving HH.

    Diabet Med. 1999 May;16(5):388-94.PMID: 10342338 [PubMed - indexed for MEDLINE]Related articles

    10.

    Progression of diabetic nephropathy.

    Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH.

    Kidney Int. 2001 Feb;59(2):702-9.PMID: 11168952 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.

    Brocco E, Velussi M, Cernigoi AM, Abaterusso C, Bruseghin M, Carraro A, Sambataro M, Piarulli F, Sfriso A, Nosadini R.

    J Nephrol. 2001 Nov-Dec;14(6):461-71.PMID: 11783602 [PubMed - indexed for MEDLINE]Related articles

    12.

    Progression of diabetic nephropathy in normotensive type 1 diabetic patients.

    Jacobsen P, Rossing K, Tarnow L, Rossing P, Mallet C, Poirier O, Cambien F, Parving HH.

    Kidney Int Suppl. 1999 Jul;71:S101-5.PMID: 10412749 [PubMed - indexed for MEDLINE]Related articles

    13.

    PC-1 amino acid variant (K121Q) has no impact on progression of diabetic nephropathy in type 1 diabetic patients.

    Jacobsen P, Grarup N, Tarnow L, Parving HH, Pedersen O.

    Nephrol Dial Transplant. 2002 Aug;17(8):1408-12.PMID: 12147787 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Stable glomerular filtration rate in normotensive IDDM patients with stable microalbuminuria. A 5-year prospective study.

    Mathiesen ER, Feldt-Rasmussen B, Hommel E, Deckert T, Parving HH.

    Diabetes Care. 1997 Mar;20(3):286-9.PMID: 9051373 [PubMed - indexed for MEDLINE]Related articles

    15.

    Pregnancy and progression of diabetic nephropathy.

    Rossing K, Jacobsen P, Hommel E, Mathiesen E, Svenningsen A, Rossing P, Parving HH.

    Diabetologia. 2002 Jan;45(1):36-41.PMID: 11845221 [PubMed - indexed for MEDLINE]Related articles

    16.

    The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy.

    Gall MA, Nielsen FS, Smidt UM, Parving HH.

    Diabetologia. 1993 Oct;36(10):1071-8.PMID: 8243857 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.

    Crepaldi G, Carta Q, Deferrari G, Mangili R, Navalesi R, Santeusanio F, Spalluto A, Vanasia A, Villa GM, Nosadini R.

    Diabetes Care. 1998 Jan;21(1):104-10.PMID: 9538979 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria.

    Gaede P, Tarnow L, Vedel P, Parving HH, Pedersen O.

    Nephrol Dial Transplant. 2004 Nov;19(11):2784-8. Epub 2004 Aug 24.PMID: 15328385 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Fish oil in diabetic nephropathy.

    Rossing P, Hansen BV, Nielsen FS, Myrup B, Hølmer G, Parving HH.

    Diabetes Care. 1996 Nov;19(11):1214-9.PMID: 8908382 [PubMed - indexed for MEDLINE]Related articles

    20.

    Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy.

    Hovind P, Tarnow L, Oestergaard PB, Parving HH.

    Kidney Int Suppl. 2000 Apr;75:S56-61.PMID: 10828763 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data